Quick Answer
Enveric Biosciences, Inc. reported Common Stock Shares Outstanding of 1.06 million shares for the year ending 2025.
- Enveric Biosciences, Inc. showed an increase of +1,778.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: 6.50 million shares | Q3 2011: 12.14 million shares | Q1 2012: 12.14 million shares | Q2 2012: 12.14 million shares | Q3 2012: 12.14 million shares | Q1 2013: 12.14 million shares | Q2 2013: 12.14 million shares | Q3 2013: 12.14 million shares | Q2 2014: 15.41 million shares | Q3 2014: 15.41 million shares | Q4 2014: 15.41 million shares | Q1 2015: 9.99 million shares | Q3 2015: 11.64 million shares | Q4 2015: 11.64 million shares | Q1 2016: 11.87 million shares | Q2 2016: 13.49 million shares | Q3 2016: 13.49 million shares | Q1 2017: 14.58 million shares | Q2 2017: 14.65 million shares | Q3 2017: 15.86 million shares | Q1 2018: 18.79 million shares | Q2 2018: 19.01 million shares | Q3 2018: 22.95 million shares | Q1 2019: 50.32 million shares | Q2 2019: 52.42 million shares | Q3 2019: 62.82 million shares | Q1 2020: 3.25 million shares | Q2 2020: 5.16 million shares | Q3 2020: 5.74 million shares | Q1 2021: 19.45 million shares | Q2 2021: 21.43 million shares | Q3 2021: 31.38 million shares | Q1 2022: 52.62 million shares | Q2 2022: 1.05 million shares | Q3 2022: 2.08 million shares | Q1 2023: 2.08 million shares | Q2 2023: 2.14 million shares | Q3 2023: 2.18 million shares | Q1 2024: 7.29 million shares | Q2 2024: 7.88 million shares | Q3 2024: 8.99 million shares | Q1 2025: 15 shares | Q1 2025: 2.47 million shares | Q2 2025: 3.03 million shares | Q3 2025: 518,296 shares.
- Over the full 15 years of available data (2010 to 2025), Enveric Biosciences, Inc.'s Common Stock Shares Outstanding has declined by 83.7%.
- Historical annual values: Fiscal year 2025: 1.06 million shares | Fiscal year 2024: 56,501 shares | Fiscal year 2023: 182,625 shares | Fiscal year 2022: 2.08 million shares | Fiscal year 2021: 651,921 shares | Fiscal year 2020: 10.10 million shares | Fiscal year 2019: 5.31 million shares | Fiscal year 2018: 1.69 million shares | Fiscal year 2017: 18.16 million shares | Fiscal year 2016: 13.89 million shares | Fiscal year 2014: 15.41 million shares | Fiscal year 2013: 12.14 million shares | Fiscal year 2012: 12.14 million shares | Fiscal year 2011: 12.14 million shares | Fiscal year 2010: 6.50 million shares.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: